Translating the basic knowledge of mitochondrial functions to metabolic therapy: Role of L-carnitine

Translational Research

Volumn 161, Issue 2, 2013, Pages 73-84

  Marcovina, Santica M ^a   Sirtori, Cesare ^b   Peracino, Andrea ^c   Gheorghiade, Mihai ^d   Borum, Peggy ^e   Remuzzi, Giuseppe ^f   Ardehali, Hossein ^d  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF MILAN   (Italy)

^c Fondazione Giovanni Lorenzini Medical Science Foundation   (Italy)

^d NORTHWESTERN UNIVERSITY   (United States)

^e UNIVERSITY OF FLORIDA   (United States)

^f MARIO NEGRI INST PHARMACOL RES   (Italy)

Author keywords

adenosine 5' triphosphate; ATP; blood pressure; BP; CoA; CoASH; coenzyme A; endothelial nitric oxide synthase; eNOS; FA; fatty acid; free coenzyme A; lipoprotein(a); Lp(a); nitric oxide; NO; oxidative phosphorylation system; OXPHOS; reactive oxygen species; ROS

Indexed keywords

ACYL COENZYME A; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARNITINE; DIACYLGLYCEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INSULIN; LEVACECARNINE; LIPOPROTEIN A; MINERALOCORTICOID ANTAGONIST; NICOTINIC ACID; PEROXYNITRITE; SIRTUIN 1; SIRTUIN 2; SIRTUIN 3; SIRTUIN 4; SIRTUIN 5; SIRTUIN 6; SIRTUIN 7;

ACETYLATION; AMINO ACID BLOOD LEVEL; AMINO ACID SYNTHESIS; APOPTOSIS; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR DISEASE; CELL METABOLISM; CELL PROTECTION; CHRONIC DISEASE; DEACETYLATION; DIABETES MELLITUS; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DRUG EFFICACY; DYSLIPOPROTEINEMIA; ENDOTHELIAL DYSFUNCTION; ENERGY METABOLISM; FATTY ACID METABOLISM; FATTY ACID OXIDATION; FATTY ACID TRANSPORT; GENE EXPRESSION; GLUCOSE UTILIZATION; HEART FAILURE; HEMODIALYSIS; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; KIDNEY FAILURE; LIPID METABOLISM; MITOCHONDRIAL GENE; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OXIDATIVE PHOSPHORYLATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; VASCULAR DISEASE;

EID: 84872387402     PISSN: 19315244     EISSN: 18781810     Source Type: Journal    
DOI: 10.1016/j.trsl.2012.10.006     Document Type: Review

References (102)

1. D.C. Chan Mitochondrial dynamics in disease N Engl J Med 356 2007 1707 1709
2. S. Neubauer The failing heart-an engine out of fuel N Engl J Med 356 2007 1140 1151
3. N.R. Madamanchi, and M.S. Runge Mitochondrial dysfunction in atherosclerosis Circ Res 100 2007 460 473
4. M. Hulsmans, E. Van Dooren, and P. Holvoet Mitochondrial reactive oxygen species and risk of atherosclerosis Curr Atheroscler Rep 14 2012 264 276
5. D.K. Coletta, and L.J. Mandarino Mitochondrial dysfunction and insulin resistance from the outside in: extracellular matrix, the cytoskeleton, and mitochondria Am J Physiol Endocrinol Metab 301 2011 E749 E755
6. J. Szendroedi, E. Phielix, and M. Roden The role of mitochondria in insulin resistance and type 2 diabetes mellitus Nat Rev Endocrinol 13 2011 92 103
7. K.F. Petersen, S. Dufour, and D.B. Savage The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome Proc Natl Acad Sci U S A 104 2007 12587 12594
8. R.H. Eckel, K.G. Alberti, S.M. Grundy, and P.Z. Zimmet The metabolic syndrome Lancet 375 2010 181 183
9. B.B. Kahn, and J.S. Flier Obesity and insulin resistance J Clin Invest 106 2000 473 481
10. K.F. Petersen, D. Befroy, and S. Dufour Mitochondrial dysfunction in the elderly: possible role in insulin resistance Science 300 2003 1140 1142
11. D.E. Kelley, J. He, E.V. Menshikova, and V.B. Ritov Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes Diabetes 51 2002 2944 2950
12. M.E. Patti, and S. Corvera The role of mitochondria in the pathogenesis of type 2 diabetes Endocr Rev 31 2010 364 395
13. M.A. Abdul-Ghani, and R.A. DeFronzo Pathogenesis of insulin resistance in skeletal muscle J Biomed Biotechnol 2010 2010 476279
14. E.M. Broad, R.J. Maughan, and S.D.R. Galloway Effects of exercise intensity and altered substrate availability on cardiovascular and metabolic responses to exercise after oral carnitine supplementation in athletes Int J Sport Nutr Exerc Metab 21 2011 385 397
15. J.P. Kovalik, D. Slentz, and R.D. Stevens Metabolic remodeling of human skeletal myocytes by cocultured adipocytes depends on the lipolytic state of the system Diabetes 60 2011 1882 1893
16. T.R. Koves, J.R. Ussher, and R.C. Noland Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance Cell Metab 7 2008 45 56
17. K. Eckardt, A. Taube, and J. Eckel Obesity-associated insulin resistance in skeletal muscle: role of lipid accumulation and physical inactivity Rev Endocr Metab Disord 12 2011 163 172
18. D.R. Green, L. Galluzzi, and G. Kroemer Mitochondria and the autophagy-inflammation-cell death axis in organismal aging Science 333 2011 1109 1112
19. P. Vallance, J. Collier, and S. Moncada Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man Lancet 2 1989 997 1000
20. E. Schulz, T. Jansen, and P. Wenzel Nitric oxide, tetrahydrobiopterin, oxidative stress, and endothelial dysfunction in hypertension Antioxid Redox Signal 10 2008 1115 1126
21. C. Antoniades, C. Shirodaria, and N. Warrick 5-methyltetrahydrofolate rapidly improves endothelial function and decreases superoxide production in human vessels: effects on vascular tetrahydrobiopterin availability and endothelial nitric oxide synthase coupling Circulation 114 2006 1193 1201
22. S.M. Shenouda, M.E. Widlansky, and K. Chen Altered mitochondrial dynamics contributes to endothelial dysfunction in diabetes mellitus Circulation 124 2011 444 453
23. M. Gheorghiade, and P.S. Pang Acute heart failure syndromes J Am Coll Cardiol 53 2009 557 573
24. G.M. Felker, P.S. Pang, K.F. Adams International AHFS Working Group Clinical trials of pharmacological therapies in acute heart failure syndromes: lessons learned and directions forward Circ Heart Fail 3 2010 314 325
25. V. Soukoulis, J.B. Dihu, and M. Sole Micronutrient deficiencies an unmet need in heart failure J Am Coll Cardiol 54 2009 1660 1673
26. M. van Bilsen, P.J. Smeets, A.J. Gilde, and G.J. van der Vusse Metabolic remodelling of the failing heart: the cardiac burn-out syndrome? Cardiovasc Res 61 2004 218 226
27. H. Ardehali, H.N. Sabbah, and M.A. Burke Targeting myocardial substrate metabolism in heart failure: potential for new therapies Eur J Heart Fail 14 2012 120 129
28. D. Leslie, and M. Gheorghiade Is there a role for thiamine supplementation in the management of heart failure? Am Heart J 131 1996 1248 1250
29. J.C. Tardiff, T.E. Hewett, and B.M. Palmer Cardiac troponin T mutations result in allele-specific phenotypes in a mouse model for hypertrophic cardiomyopathy J Clin Invest 104 1999 469 481
30. V.G. Sharov, A. Goussev, and M. Lesch Abnormal mitochondrial function in myocardium of dogs with chronic heart failure J Mol Cell Cardiol 30 1998 1757 1762
31. U. Baandrup, R.A. Florio, F. Roters, and E.G. Olsen Electron microscopic investigation of endomyocardial biopsy samples in hypertrophy and cardiomyopathy. A semiquantitative study in 48 patients Circulation 63 1981 1289 1298
32. M.G. Rosca, and C.L. Hoppel Mitochondria in heart failure Cardiovasc Res 88 2010 40 50
33. M. Sebastiani, C. Giordano, and C. Nediani Induction of mitochondrial biogenesis is a maladaptive mechanism in mitochondrial cardiomyopathies J Am Coll Cardiol 50 2007 1362 1369
34. E.S. Weinstein, D.W. Benson, and D.E. Fry Subpopulations of human heart mitochondria J Surg Res 40 1986 495 498
35. E.R. Dabkowski, C.L. Williamson, and V.C. Bukowski Diabetic cardiomyopathy-associated dysfunction in spatially distinct mitochondrial subpopulations Am J Physiol 296 2009 H359 H369
36. J. Duan, and M. Karmazyn Relationship between oxidative phosphorylation and adenine nucleotide translocase activity of two populations of cardiac mitochondria and mechanical recovery of ischemic hearts following reperfusion Can J Physiol Pharmacol 67 1989 704 709
37. L.L. Jones, D.A. McDonald, and P.R. Borum Acylcarnitines: role in brain Prog Lipid Res 49 2010 61 75
38. C.J. Rebouche Carnitine function and requirements during the life cycle FASEB J 6 1992 3379 3386
39. A.L. Kerbey, P.J. Randle, R.H. Cooper, S. Whitehouse, H.T. Pask, and R.M. Denton Regulation of pyruvate dehydrogenase in rat heart. Mechanism of regulation of proportions of dephosphorylated and phosphorylated enzyme by oxidation of fatty acids and ketone bodies and of effects of diabetes: role of coenzyme A, acetyl-coenzyme A and reduced and oxidized nicotinamide-adenine dinucleotide Biochem J 154 1976 327 348
40. Wc Huelsmann, D. Siliprandi, M. Ciman, and N. Siliprandi Effect of carnitine on the oxidation of alpha-oxoglutarate to succinate in the presence of acetoacetate or pyruvate Biochim Biophys Acta 93 1964 166 168
41. R.R. Russell III, and H. Taegtmeyer Coenzyme A sequestration in rat hearts oxidizing ketone bodies J Clin Invest 89 1992 968 973
42. H. Schulz Regulation of fatty acid oxidation in heart J Nutr 124 1994 165 171
43. G.B. Quistad, L.E. Staiger, and D.A. Schooley The role of carnitine in the conjugation of acidic xenobiotics Drug Metab Dispos 14 1986 521 525
44. R.A. Chalmers, C.R. Roe, T.E. Stacey, and C.L. Hoppel Urinary excretion of L-carnitine and acylcarnitines by patients with disorders of organic acid metabolism: evidence for secondary insufficiency of L-carnitine Pediatric Res 18 1984 1326 1328
45. C.A. Stanley Carnitine deficiency disorders in children Ann N Y Acad Sci 1033 2004 42 51
46. F.B. Stephens, D. Constantin-Teodosiu, and P.L. Greenhaff New insights concerning the role of carnitine in the regulation of fuel metabolism in skeletal muscle J Physiol 581 2007 431 444
47. C.J. Rebouche Kinetics, pharmacokinetics, and regulation of L-carnitine and acetyl-L-carnitine metabolism Ann N Y Acad Sci 1033 2004 30 41
48. C.R. Roe, D.S. Millington, D.A. Maltby, S.G. Kahler, and T.P. Bohan L-carnitine therapy in isovaleric acedemia J Clin Invest 74 1984 2290 2295
49. C.R. Roe, D.S. Millington, D.A. Maltby, and C.L. Hoppel L-carnitine enhances excretion of propionyl coenzyme A as propionylcarnitine in propionic acidemia J Clin Invest 73 1984 1785 1788
50. N. Andrieu-Abadie, J.P. Jaffrezou, S. Hatem, G. Laurent, T. Levade, and J.J. Mercadier L-carnitine prevents doxorubicin-induced apoptosis of cardiac myocytes: role of inhibition of ceramide generation FASEB J 13 1999 1501 1510
51. M.C. Mutomba, H. Yuan, and M. Konyavko Regulation of the activity of caspases by L-carnitine and palmitoylcarnitine FEBS Lett 478 2000 19 25
52. M.B. Paumen, Y. Ishida, M. Muramatsu, M. Yamamoto, and T. Honjo Inhibition of carnitine palmitoyltransferase I augments sphingolipid synthesis and palmitate-induced apoptosis J Biol Chem 272 1997 3324 3329
53. G. Cederbland, and S. Lindstedt A method for the determination of carnitine in the picomole range Clinica Chimica Acta 37 1972 235 243
54. J.H. Osorio, and M. Pourfarzam Plasma free and total carnitine measured in children by tandem mass spectrometry Brazilian J Med Biol Res 35 2002 1265 1271
55. J. Sowell, M. Fuqua, and T. Wood Quantification of total and free carnitine in human plasma by hydrophilic interaction liquid chromatography tandem mass spectrometry J Chromatogr Sci 49 2001 463 468
56. P.E. Minkler, M.S.K. Stoll, and S. Ingalls Quantification of carnitine and acylcarnitines in biological matrices by HPLC electrospray ioniztion-mass spectrometry Clin Chem 54 2008 1451 1462
57. J. Liu, D.W. Killilea, and B.N. Ames Age-associated mitochondrial oxidative decay: improvement of carnitine acetyltransferase substrate-binding affinity and activity in brain by feeding old rats acetyl-L- carnitine and/or R-alpha-lipoic acid Proc Natl Acad Sci U S A 99 2002 1876 1881
58. I. Gülçin Antioxidant and antiradical activities of L-carnitine Life Sci 78 2006 803 811
59. A. Arduini Carnitine and its acyl esters as secondary antioxidants? Am Heart J 123 1992 1726 1727
60. L.A. Calò, E. Pagnin, and P.A. Davis Antioxidant effect of L-carnitine and its short chain esters: relevance for the protection from oxidative stress related cardiovascular damage Int J Cardiol 107 2006 54 60
61. M.A. Stasi, M.G. Scioli, and G. Arcuri Propionyl-L-carnitine improves postischemic blood flow recovery and arteriogenetic revascularization and reduces endothelial NADPH-oxidase 4-mediated superoxide production Arterioscler Thromb Vasc Biol 30 2010 426 435
62. J.L. Flanagan, P.A. Simmons, J. Vehige, M.D. Willcox, and Q. Garrett Role of carnitine in disease Nutr Metab (Lond) 7 2010 30
63. B. Capaldo, R. Napoli, P. Di Bonito, G. Albano, and L. Saccà Carnitine improves peripheral glucose disposal in non-insulin-dependent diabetic patients Diabetes Res Clin Pract 14 1991 191 195
64. G. Mingrone Carnitine in type 2 diabetes Ann N Y Acad Sci 1033 2004 99 107
65. D.W. Foster The role of the carnitine system in human metabolism Ann N Y Acad Sci 1033 2004 1 16
66. P. Ruggenenti, D. Cattaneo, and G. Loriga Ameliorating hypertension and insulin resistance in subjects at increased cardiovascular risk: effects of acetyl-L-carnitine therapy Hypertension 54 2009 567 574
67. G. Mingrone, A.V. Greco, and E. Capristo L-carnitine improves glucose disposal in type 2 diabetic patients J Am Coll Nutr 18 1999 77 82
68. A. Giancaterini, A. De Gaetano, and G. Mingrone Acetyl-L-carnitine infusion increases glucose disposal in type 2 diabetic patients Metabolism 49 2000 704 708
69. A.E. Midaoui, A. Elimadi, L. Wu, P.S. Haddad, and J. de Champlain Lipoic acid prevents hypertension, hyperglycemia, and the increase in heart mitochondrial superoxide production Am J Hypertens 16 2003 173 179
70. S. Vasdev, V. Gill, S. Parai, and V. Gadag Dietary lipoic acid supplementation attenuates hypertension in Dahl salt sensitive rats Mol Cell Biochem 275 2005 135 141
71. E. Ferrannini, A. Natali, B. Capaldo, M. Lehtovirta, S. Jacob, and H. Yki-Järvinen Insulin resistance, hyperinsulinemia, and blood pressure: role of age and obesity. European Group for the Study of Insulin Resistance (EGIR) Hypertension 30 1997 1144 1149
72. A. Whaley-Connell, and J.R. Sowers Hypertension and insulin resistance Hypertension 54 2009 462 464
73. K.K. Cheng, K.S. Lam, and Y. Wang Adiponectin-induced endothelial nitric oxide synthase activation and nitric oxide production are mediated by APPL1 in endothelial cells Diabetes 56 2007 1387 1394
74. H. Chen, M. Montagnani, T. Funahashi, I. Shimomura, and M.J. Quon Adiponectin stimulates production of nitric oxide in vascular endothelial cells J Biol Chem 278 2003 45021 45026
75. W. Zhu, K.K. Cheng, P.M. Vanhoutte, K.S. Lam, and A. Xu Vascular effects of adiponectin: molecular mechanisms and potential therapeutic intervention Clin Sci (Lond) 114 2008 361 374
76. J. Bełtowski, A. Jamroz-Wiśniewska, and S. Widomska Adiponectin and its role in cardiovascular diseases Cardiovasc Hematol Disord Drug Targets 8 2008 7 46
77. R.A. DeFronzo Pathogenesis of type 2 diabetes mellitus Med Clin North Am 88 2004 787 835
78. T.M. Hagen, J. Liu, and J. Lykkesfeldt Feeding acetyl-L-carnitine and lipoic acid to old rats significantly improves metabolic function while decreasing oxidative stress Proc Natl Acad Sci U S A 99 2002 1870 1875
79. J.L. Miguel-Carrasco, A. Mate, M.T. Monserrat, J.L. Arias, O. Aramburu, and C.M. Vázquez The role of inflammatory markers in the cardioprotective effect of L-carnitine in L-NAME-induced hypertension Am J Hypertens 21 2008 1231 1237
80. A. Mate, J.L. Miguel-Carrasco, M.T. Monserrat, and C.M. Vázquez Systemic antioxidant properties of L-carnitine in two different models of arterial hypertension J Physiol Biochem 66 2010 127 136
81. S. Hedayati Dialysis-related carnitine disorder Semin Dial 19 2006 323 328
82. B.D. Schreiber Debte forum: levocarnitine therapy is rational and justified in selected dialysis patients Blood Purif 24 2006 128 134
83. M. Bohomini Pharmacological use of L-carnitine in uremic anemia: has its full potential been exploited? Pharmacol Res 63 2011 157 164
84. I. Anand, Y. Chandrashekhan, and F. De Giuli Acute and chronic effects of propionyl-L-carnitine on the hemodynamics, exercise capacity, and hormones in patients with congestive heart failure Cardiovasc Drugs Ther 12 1998 291 299
85. E. Oyanagi, H. Yano, M. Uchida, K. Utsumi, and J. Sasaki Protective action of L-carnitine on cardiac mitochondrial function and structure against fatty acid stress Biochem Biophys Res Commun 412 2011 61 67
86. E.J. Lesnefsky, and C.L. Hoppel Oxidative phosphorylation and aging Aging Res Rev 5 2006 402 433
87. M.G. Rosca, H. Lemieux, and C.L. Hoppel Mitochondria in the elderly: is acetylcarnitine a rejuvenator Adv Drug Deliv Rev 61 2009 1332 1342
88. Hagen TM, Moreau R, Suh JH, Visioli F. Mitochondrial decay in the agine rat heart: evidence for improvement y Ann NY Acad Sci 2002;959:491-507.
89. V. Pesce, L. Nicassio, F. Fracasso, C. Musicco, P. Cantatore, and M.N. Gadaleta Acetyl-L-carnitine activates the peroxisome proliferator-activated receptor-γ coactivators PGC-1α/PGCβ-dependent signaling cascade of mitochondrial biogenesis and decreases the oxidized peroxiredoxins content in old rat liver Rejuvenation Res 15 2012 136 139
90. C. Musicco, V. Capelli, and V. Pesce Rat liver mitochondrial proteome: changes associated with aging and acetyl-L-carnitne treatment J Proteomics 74 2011 2536 2547
91. L. Guarente Sirtuins, aging, and metabolism Cold Spring Harb Symp Quant Biol 76 2011 81 90
92. D.B. Lombard, W. Ahf, and H.L. Cheng Mammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylation Mol Cell Biol 24 2007 8807 8814
93. M.D. Hirschey, T. Shimazu, and E. Goetzman SIR3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation Nature 464 2010 121 125
94. E. Jing, B. Emanuelli, and M.D. Hirschey Sirtuin-3 (Sirt3) regulates skeletal muscle metabolism and insulin signaling via altered mitochondrial oxidation and reactive oxygen species production Proc Natl Acad Sci U S A 108 2011 14608 14613
95. A. Benigni, C. Daniela, and C. Zoja Disruption of the Ang II type 1 receptor promotes longevity in mice J Clin Invest 119 2009 524 530
96. Emerging Risk Factors Collaboration S. Erqou, S. Kaptoge, and P.L. Perry Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality JAMA 302 2009 412 423
97. P.R. Kamstrup, A. Tybjaerg-Hansen, R. Steffensen, and B.G. Nordestgaard Genetically elevated lipoprotein(a) and increased risk of myocardial infarction JAMA 301 2009 2331 2339
98. R. Clarke, J.F. Peden, J.C. Hopewell PROCARDIS Consortium Genetic variants associated with Lp(a) lipoprotein level and coronary disease N Engl J Med 361 2009 2518 2528
99. M.L. Koschinsky, and S.M. Marcovina Structure-function relationships in apolipoprotein(a): insights into lipoprotein(a) assembly and pathogenicity Curr Opin Lipidol 15 2004 167 174
100. Z. Benyó, A. Gille, and J. Kero GPR109A (PUMA-G/HM74A) mediates nicotinic acid-induced flushing J Clin Invest 115 2005 3634 3640
101. C.R. Sirtori, L. Calabresi, and S. Ferrara L-carnitine reduces plasma lipoprotein(a) levels in patients with hyper Lp(a) Nutr Metab Cardiovasc Dis 10 2000 247 251
102. F. Galvano, G. Li Volti, and M. Malaguarnera Effects of simvastatin and carnitine versus simvastatin on lipoprotein(a) and apoprotein(a) in type 2 diabetes mellitus Expert Opin Pharmacother 10 2009 1875 1882